Lenacapavir, sold under the brand name Sunlenca, is an antiretroviral medication used to treat HIV/AIDS. Reference standards of Lenacapavir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine [catalogue_number] => PA 12 2091002 [category_ids] => ,82,78,76,75,70, [chemical_name] => [weight] => 341.14 [form] => C15H19BF3N3O2 [cas] => 3025145-62-1 [pslug] => 3025145-62-1-7-4-4-5-5-tetramethyl-1-3-2-dioxaborolan-2-yl-1-2-2-2-trifluoroethyl-1h-indazol-3-amine-pa122091002 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 12 2091002
CAS :
Molecular Formula : C15H19BF3N3O2
Molecular Weight : 341.14
stdClass Object ( [pname] => (S)-N-(7-(2-(1-Amino-2-(3,5-Difluorophenyl)ethyl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-3-yl)-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-3-yl)methanesulfonamide [catalogue_number] => PA 12 2091015 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 704.13 [form] => C29H27ClF5N5O4S2 [cas] => 3053923-46-6 [pslug] => 3053923-46-6-s-n-7-2-1-amino-2-3-5-difluorophenyl-ethyl-6-3-methyl-3-methylsulfonyl-but-1-yn-1-yl-pyridin-3-yl-4-chloro-1-2-2-2-trifluoroethyl-1h-indazol-3-yl-methanesulfonamide-pa122091015 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 12 2091015
Molecular Formula : C29H27ClF5N5O4S2
Molecular Weight : 704.13
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....